About this trial
To compare the effects of physiology- and imaging-guided PCI combined with optimal medical therapy (OMT) versus OMT alone on the recovery of left ventricular systolic function in patients with ischemic cardiomyopathy and multivessel coronary artery disease.
Eligibility criteria
Qualifiers
Subject must be ≥ 19 years
Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic or imaging evaluation and PCI and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
Subject with LV ejection fraction <40% from cardiac MRI
Subject with multivessel disease in major epicardial coronary artery disease or their major branches (vessel size of 2.5 mm or more than 2.5mm) considering coronary revascularization
Disqualifiers
Subjects with more than 50% transmural extent of infarction on GE-MRI in more than 25% of the dysfunctional myocardial segments
Subject with suspicious of other cardiomyopathy (dilated cardiomyopathy, hypertrophic cardiomyopathy etc.)
Subject with recent myocardial infarction within 4 weeks
Subject with recent fatal arrhythmia (VT or VF) within 4 weeks
Trial design
Treatments tested in this trial
- Physiology-and imaging-guided PCI
- Optimal medical treatment
Treatment groups
Locations
1Sponsors and collaborators
Seoul National University Hospital
Lead sponsor
Seoul National University Bundang Hospital
Collaborator
Seoul National University Boramae Hospital
Collaborator